Back to 
Jane Street Group, LLC
Jane Street Group, LLC
BBIO
25 quarters
Position history for Jane Street Group, LLC's holdings in BridgeBio Pharma, Inc.
Yes. Jane Street Group holds 2,934,193 shares of BBIO (BridgeBio Pharma), worth $218.5M, as of its Q2 2026 13F filing. It increased the position by 1,176,521 shares (+66.9%) from Q1 2026. Jane Street Group has held BBIO since Q2 2020, across 25 quarterly 13F filings.
Current Value
$218.5M
Current Shares
2.9M
Total Value Change
+$218.2M
Total Shares Change
+2.9M
Quarter-by-Quarter History
Other major holders of BBIO: Viking Global Investors LP, Vanguard Group Inc.